Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia ...Middle East

- Iomab-B met the primary endpoint of durable Complete Remission (dCR) of 6-months following initial complete remission after BMT with high statistical significance (p-value of

Hence then, the article about actinium announces positive full data results from the pivotal phase 3 sierra trial in patients with active relapsed or refractory acute myeloid leukemia was published today ( Sunday 19/02/2023 - 12:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia )

Also on site :

• Today's Famous Celebrity Birthdays for March 22, 2026: Reese Witherspoon, William Shatner
• Firefighters rush to Morrisons convenience store in Oswestry after report of fire
• Iranian Revolutionary Guard: 200 Killed and Wounded Among Zionist Enemy in 73rd Wave